Preoperative neurocognitive function as an independent survival prognostic marker in primary glioblastoma.

Evangelia Liouta Christos Koutsarnakis Spyridon Komaitis Aristotelis V Kalyvas Evangelos DrososJuan M García-GómezJavier Juan-AlbarracínVasileios K KatsarosLampis StavrinouGeorge Stranjalis

Published in: Neuro-oncology practice (2023)

Our study demonstrates that neurocognitive status at baseline-prior to treatment-is an independent prognostic factor for OS in wild-type GBM patients, adding another prognostic tool to assist physicians in selecting the best treatment plan.

Keyphrases

prognostic factors
wild type
end stage renal disease
primary care
ejection fraction
patients undergoing
peritoneal dialysis
combination therapy
free survival
patient reported outcomes
replacement therapy